FDA Takes New Regulatory Action Against Ranbaxy?s Paonta Sahib Plant in India

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: FDA Takes New Regulatory Action Against Ranbaxy’s Paonta Sahib Plant in India

FDA Takes New Regulatory Action Against Ranbaxy’s Paonta Sahib Plant in India
Wed, 25 Feb 2009 11:40:00 -0600

The U.S. Food and Drug Administration today announced that a facility owned by India-based Ranbaxy Laboratories falsified data and test results in approved and pending drug applications. The facility, Paonta Sahib, has been under an FDA Import Alert since September 2008.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420